Europe Drug-Device Combination Market – Industry Trends and Forecast to 2028

Customize Your Report Customize Your Report Buy Now Buy Now Free Sample Report Free Sample Report
Home Healthcare Europe Drug Device Combination Market
Request for TOC Request for TOC Speak to Analyst Speak to Analyst Buy Now Buy Now Inquire Before Buying Inquire Before Free Sample Report Free Sample Report

Europe Drug-Device Combination Market – Industry Trends and Forecast to 2028

  • Healthcare
  • Published Report
  • Sep 2021
  • Europe
  • 350 Pages
  • No of Tables: 85
  • No of Figures: 46
Buy Now Buy Now

Europe Drug Device Combination Market

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period
 2021 –2028
Diagram Market Size (Base Year)
 USD 3,142.68 Million
Diagram Market Size (Forecast Year)
 USD 6,359.42 Million
Diagram CAGR
 %
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5
Request For Unlock

Europe drug-device combination market, By Product (Auto-Injector, Microneedle Patch, Digital Pill, Smart Inhaler, Drug Delivery Hydrogels, Drug-Eluting Lens and Others), Application Type (Orthopedic Diseases, Respiratory Diseases, Diabetes, Oncology, Cardiovascular Diseases, and Others), End User (Clinics, Hospitals, Home Care Settings, Ambulatory Care Centers and Others), Distribution Channel (Direct Tender, Retail Sales and Others), Country (U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Belgium, Turkey and Rest Of Europe) Industry Trends and Forecast To 2028.

Europe Drug-Device Combination Market Market Analysis and Insights: Europe Drug-Device Combination Market

The drug-device combination market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 9.7% in the forecast period of 2021 to 2028 and is expected to reach USD 6,359.42 million by 2028 from USD 3,142.68 million in 2020. The presence of advance and developed healthcare systems act as the major drivers which boost the demand for the drug-device combination products in the forecast period.

The increase in the prevalence of chronic diseases and advancement in technology effectively help the growth of the drug-device combination market. However, the limitations and complications associated with the medical devices may hamper the future growth of the drug-device market. The partnerships and collaborations by major market players act as an opportunity for the growth of the drug-device combination market.  However, strict regulatory framework acts as a challenge for the growth of the drug-device combination market.

The drug-device combination market report provides details of market share, new developments, and product pipeline analysis, the impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario, contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.   

Europe Drug-Device Combination Market Europe Drug-Device Combination Market - Scope and Market Size

The drug-device combination market is segmented on the basis of product, application, end user, and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of product, the drug-device combination market is segmented into auto-injector, microneedle patch, digital pill, smart inhaler, drug delivery hydrogels, drug-eluting lens, and others. Auto-injector is further sub-segmented into wearable auto-injector, hand-held auto-injector. In 2021, the auto-injector is expected to dominate the drug-device combination market as a rise in the adoption of home care settings and self-administration medication.
  • On the basis of application, the drug-device combination market is segmented into orthopedic diseases, respiratory diseases, diabetes, oncology, cardiovascular diseases, and others. In 2021, the orthopedic is expected to dominate the drug-device combination market due to an increase in the geriatric population and government funding in drug-device combination products, accelerating market growth.
  • On the basis of end user, the drug-device combination market is segmented into clinics, hospitals, home care settings, ambulatory care centers, and others. In 2021, the clinics are expected to dominate the drug-device combination market as patients need experts for personalized care and management of chronic diseases.
  • On the basis of distribution channel, the drug-device combination market is segmented into direct tender, retail sales, and others. In 2021, the direct tender is expected to dominate the drug-device combination market due to direct interaction with end users, which enhanced accessibility, affordability, and availability.

 Drug-Device Combination Market - Country Level Analysis

The drug-device combination market is analyzed, and market size information is provided by product, application, end user, and distribution channel.

The countries covered in the drug-device combination market report are the U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Turkey, Belgium and rest of Europe.   

Europe is expected to grow with a significant growth rate in the forecast period of 2021 to 2028 due to high technology-based healthcare infrastructure and increasing healthcare expenditure in the region. Germany is dominating the European market with the increasing advancement in the drug-device combination industry in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impact the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts, and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, the presence and availability of European brands and their challenges faced due to large or scarce competition from local and domestic brands, the impact of sales channels are considered while providing forecast analysis of the country data.  

Increasing Collaboration by the Player for Advanced Drug-Device Combination is Creating New Opportunities for players in the drug-device combination market    

The drug-device combination market also provides you with a detailed market analysis for every country's growth in a particular market. Additionally, it provides detailed information regarding the market players’ strategy and their geographical presence. The data is available for the historical period 2010 to 2019

Competitive Landscape and Drug-Device Combination Market Share Analysis

Drug-Device combination market competitive landscape provides details by the competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width, and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to the drug-device combination market.

The major players covered in the report are Medtronic, Zimmer Biomet, Amgen Inc., B.D., Findair Sp. z o. o., MetP Pharma AG, SONCEBOZ, Eitan Medical,  Vaxess Technologies Inc., Subcuject Aps, GlaxoSmithKline plc, Bayer AG, Sensirion AG Switzerland, Janssen Pharmaceuticals, Inc.(a subsidiary of Johnson & Johnson Sevices, Inc.), Insulet Corporation, TheraJect, Otsuka America Pharmaceutical, Inc., among other domestic and Europe players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many contracts and agreements are initiated by companies worldwide, which are also accelerating the drug-device combination market.

For instance,

  • In July 2020, Eitan Medical’s Sorrel Medical entered into a strategic partnership with pharmaceutical companies to advance the development and introduction of next-generation wearable drug delivery solutions. This augmented the growth and innovation capabilities of the firm.
  • In August 2020, Vaxess Technologies Inc. announced a contract with Biomedical Advanced Research and Development Authority (BARDA) to evaluate alternative vaccination technologies. This increased recognition of their innovative platforms like MIMIX can enable a better response to future pandemics and will boost the market.

Collaboration, joint ventures, and other strategies by the market players are enhancing the company's footprints in the drug-device combination market which provides the benefit for organization growth pace.

SKU-

Get online access to the report on the World's First Market Intelligence Cloud

Sample Image Click on image to enlarge
  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

Table of Content

  1. introduction
    1. OBJECTIVES OF THE STUDY
    2. MARKET DEFINITION
    3. OVERVIEW of EUROPE DRUG-DEVICE COMBINATION MARKET
    4. LIMITATIONS
    5. MARKETS COVERED
  2. MARKET SEGMENTATION
    1. MARKETS COVERED
    2. geographical scope
    3. years considered for the study
    4. currency and pricing
    5. DBMR TRIPOD DATA VALIDATION MODEL
    6. MULTIVARIATE MODELLING
    7. PRODUCT type LIFELINE CURVE
    8. primary interviews with key opinion leaders
    9. DBMR MARKET POSITION GRID
    10. market application coverage grid
    11. vendor share analysis
    12. secondary sourcEs
    13. assumptions
  3. EXECUTIVE SUMMARY
  4. premium insights
    1. PATENT ANALYSIS
      1. MANUFACTURING PROCESS OF COMBINATION PRODUCTS
      2. APPROVAL BY AGENCY
      3. PATENT GRANT
      4. PATENT CERTIFICATIONS:
  5. Pipeline analysis
  6. REGULATORY FRAMEWORKS:
    1. U.S.
    2. EUROPE
    3. CANADA
    4. AUSTRALIA
    5. JAPAN
    6. CHINA
    7. SOUTH KOREA
  7. regional Summary
    1. North America Drug-Device Combination Market
      1. OVERVIEW
    2. Europe Drug-Device Combination Market
      1. OVERVIEW
    3. Asia-Pacific Drug-Device Combination Market
      1. OVERVIEW
    4. Middle East and Africa Drug-Device Combination Market
      1. OVERVIEW
    5. South America Drug-Device Combination Market
      1. OVERVIEW
  8. Market Overview
    1. Drivers
      1. INCREASING PREVALENCE OF chronic diseases
      2. Growing geriatric population
      3. Escalation in innovation and technologies
      4. Rising rates of obesity
    2. RESTRAINTS
      1. product recalls
      2. Risk associated with the combiNAtion products
    3. opportunities
      1. RISING EXPENDITURE ON HEALTHCARE
      2. STRATEGIC INITIATIVES BY KEY MARKET PLAYERS
      3. Growing support by healthcare organizations and government bodies
      4. INCREASE IN R&D ACTIVITIES BY MEDICAL DEVICE COMPANIES
    4. Challenge
      1. STRICT REGULATORY FRAMEWORK
  9. Impact Of COVID-19 Pandemic On The Europe Drug-Device Combination Market
    1. IMPACT ON PRICE
    2. IMPACT ON SUPPLY CHAIN
    3. IMPACT ON DEMAND
    4. STRATEGIC DECISIONS FOR MANUFACTURERS
    5. CONCLUSION
  10. EUROPE DRUG-DEVICE COMBINATION MARKET, By product
    1. overview
    2. Auto-Injector
      1. WEARABLE AUTO-INJECTOR
      2. HAND HELD AUTO-INJECTOR
    3. Microneedle Patch
    4. digital pill
    5. Smart Inhaler
    6. Drug Delivery Hydrogels
    7. Drug-Eluting Lens
    8. others
  11. EUROPE DRUG-DEVICE COMBINATION MARKET, By application
    1. overview
    2. Orthopedic Diseases
    3. Respiratory Diseases
    4. Diabetes
    5. Oncology
    6. Cardiovascular Diseases
    7. others
  12. Europe drug-device combination MARKET, BY end user
    1. overview
    2. clinics
    3. hospitals
    4. home care settings
    5. ambulatory care centers
    6. others
  13. Europe drug-device combination MARKET, BY distribution channel
    1. overview
    2. direct tender
    3. retails sales
    4. others
  14. EUROPE drug-device combination MARKET, BY REGION
    1. Europe
      1. germany
      2. france
      3. u.k.
      4. italy
      5. spain
      6. russia
      7. switzerland
      8. turkey
      9. belgium
      10. netherlands
      11. rest of europe
  15. Europe Drug-device combination Market: COMPANY landscape
    1. company share analysis: Europe
  16. Swot analysis
  17. Company profile
    1. Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.)
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. Recent development
    2. Amgen Inc.
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTs
    3. GlaxoSmithKline plc
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENT
    4. BD
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. recent developmentS
    5. MEDTRONIC
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. COMPANY SHARE ANALYSIS
      4. PRODUCT PORTFOLIO
      5. RECENT DEVELOPMENTS
    6. Bayer AG
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    7. CGBIO
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    8. CosMED Pharmaceutical Co.Ltd.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    9. E3D Elcam Drug Delivery Devices
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    10. Eitan Medical
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    11. EOFLOW CO., LTD.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    12. Findair Sp. z o. o.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    13. Insulet Corporation
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    14. Mediprint
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    15. MetP Pharma AG
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    16. Micron Biomedical, Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    17. NanoPass
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    18. OcuMedic
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    19. Otsuka America Pharmaceutical, Inc.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    20. PROPELLER HEALTH
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    21. RAPHAS CO., LTD.
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENT
    22. Sensirion AG Switzerland
      1. COMPANY SNAPSHOT
      2. revenue analysis
      3. PRODUCT PORTFOLIO
      4. Recent development
    23. . SONCEBOZ
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    24. Subcuject Aps
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    25. TheraJect
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENT
    26. Vaxess Technologies Inc.
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    27. VAXXAS
      1. COMPANY SNAPSHOT
      2. PRODUCT PORTFOLIO
      3. RECENT DEVELOPMENTS
    28. YPSOMED
      1. COMPANY SNAPSHOT
      2. REVENUE ANALYSIS
      3. PRODUCT PORTFOLIO
      4. RECENT DEVELOPMENTS
    29. Zimmer Biomet
      1. COMPANY SNAPSHOT
      2. Revenue analysis
      3. PRODUCT PORTFOLIO
      4. Recent development
  18. questionnaire
  19. related reports

List of Table

TABLE 1 Europe DRUG-DEVICE COMIBINATION Market, pipeline analysis

TABLE 2 Most obese countries of Asia-Pacific 2020

TABLE 3 EUROPE DRUG-DEVICE COMBINATION MARKET, By Product, 2019-2028 (USD million)

TABLE 4 Europe Auto-Injector in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 5 Europe Auto-Injector in Drug-Device Combination Market, By Product, 2019-2028 (USD Million)

TABLE 6 Europe Microneedle Patch in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 7 Europe Digital Pill in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 8 Europe Smart Inhaler in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 9 Europe Drug Delivery Hydrogels in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 10 Europe Drug-Eluting Lens in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 11 Europe Others in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 12 Europe Drug-Device Combination Market, By Application, 2019-2028 (USD Million)

TABLE 13 Europe Orthopedic Diseases in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 14 Europe Respiratory Diseases in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 15 Europe Diabetes in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 16 Europe Oncology in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 17 Europe Cardiovascular Diseases in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 18 Europe Others in Drug-Device Combination Market, 2019-2028 (USD Million)

TABLE 19 Europe drug-device combination Market, By end user, 2019-2028 (USD MILLION)

TABLE 20 Europe clinics in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 21 Europe hospitals in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 22 Europe home care settings in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 23 Europe ambulatory care centers in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 24 Europe ambulatory care centers in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 25 Europe drug-device combination MARKET, By distribution channel 2019-2028 (USD MILLION)

TABLE 26 Europe direct tender in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 27 Europe retail sales in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 28 Europe others in drug-device combination MARKET, By Region, 2019-2028 (USD MILLION)

TABLE 29 EUROPE DRUG-DEVICE COMBINATION market, By Country, 2019-2028 (USD Million)

TABLE 30 EUROPE DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 31 EUROPE AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 32 EUROPE DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 33 EUROPE DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 34 EUROPE DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 35 GERMANY DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 36 GERMANY AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 37 GERMANY DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 38 GERMANY DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 39 GERMANY DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 40 FRANCE DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 41 FRANCE AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 42 FRANCE DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 43 FRANCE DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 44 FRANCE DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 45 U.K. DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 46 U.K. AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 47 U.K. DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 48 U.K. DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 49 U.K. DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 50 ITALY DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 51 ITALY AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 52 ITALY DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 53 ITALY DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 54 ITALY DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 55 SPAIN DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 56 SPAIN AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 57 SPAIN DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 58 SPAIN DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 59 SPAIN DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 60 RUSSIA DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 61 RUSSIA AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 62 RUSSIA DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 63 RUSSIA DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 64 RUSSIA DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 65 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 66 SWITZERLAND AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 67 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 68 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 69 SWITZERLAND DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 70 TURKEY DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 71 TURKEY AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 72 TURKEY DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 73 TURKEY DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 74 TURKEY DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 75 belgium DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 76 BELGIUM AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 77 BELGIUM DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 78 BELGIUM DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 79 BELGIUM DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 80 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 81 NETHERLANDS AUTO-INJECTOR in DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

TABLE 82 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, By Application, 2019-2028 (USD Million)

TABLE 83 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, By END USER, 2019-2028 (USD Million)

TABLE 84 NETHERLANDS DRUG-DEVICE COMBINATION MARKET, By Distribution Channel, 2019-2028 (USD Million)

TABLE 85 REST OF EUROPE DRUG-DEVICE COMBINATION MARKET, By PRODUCT, 2019-2028 (USD Million)

List of Figure

FIGURE 1 EUROPE DRUG-DEVICE COMBINATION MARKET: segmentation

FIGURE 2 EUROPE DRUG-DEVICE COMBINATION MARKET: data triangulation

FIGURE 3 EUROPE DRUG-DEVICE COMBINATION MARKET: DROC ANALYSIS

FIGURE 4 EUROPE DRUG-DEVICE COMBINATION MARKET: Europe vs REGIONAL MARKET ANALYSIS

FIGURE 5 EUROPE DRUG-DEVICE COMBINATION MARKET: COMPANY RESEARCH ANALYSIS

FIGURE 6 EUROPE DRUG-DEVICE COMBINATION MARKET: Multivariate Modelling

FIGURE 7 EUROPE DRUG-DEVICE COMBINATION MARKET: PRODUCT type LIFELINE CURVE

FIGURE 8 EUROPE DRUG-DEVICE COMBINATION MARKET: INTERVIEW DEMOGRAPHICS

FIGURE 9 EUROPE DRUG-DEVICE COMBINATION MARKET: DBMR MARKET POSITION GRID

FIGURE 10 EUROPE DRUG-DEVICE COMBINATION MARKET: MARKET APPLICATION COVERAGE GRID

FIGURE 11 EUROPE DRUG-DEVICE COMBINATION MARKET: vendor share analysis

FIGURE 12 EUROPE DRUG-DEVICE COMBINATION MARKET: SEGMENTATION

FIGURE 13 THE increasing prevalence of chronic diseases and rising geriatric population are expected to drive THE EUROPE DRUG-DEVICE COMBINATION MARKET IN THE FORECAST PERIOD of 2021 to 2028

FIGURE 14 THE Auto-Injector segment is expected to account for the largest share of the EUROPE DRUG-DEVICE COMBINATION MARKET IN THE Year 2021 & 2028

FIGURE 15 Porter's 5 forces

FIGURE 16 Pestel's Model

FIGURE 17 DRIVERS, RESTRAINTS, Opportunities, and Challenges: EUROPE DRUG-DEVICE COMBINATION MARKET

FIGURE 18 PREVALENCE OF ASTHMA IN THE FOLLOWING COUNTRIES.

FIGURE 19 INCIDENCE OF CANCER, WHICH INCREASES WITH AGE

FIGURE 20 AGEING POPULATION In the world (in millions)

FIGURE 21 North AMERICA AGEING POPULATION (In million)

FIGURE 22 Europe AGEING POPULATION (In million)

FIGURE 23 Asia-pacific AGEING POPULATION (In million)

FIGURE 24 Medical Device Spending vs. National Health Expenditures, 2016

FIGURE 25 EUROPE DRUG-DEVICE COMBINATION MARKET: By PRODUCT, 2020

FIGURE 26 EUROPE DRUG-DEVICE COMBINATION MARKET: By PRODUCT, 2019-2028 (USD million)

FIGURE 27 EUROPE DRUG-DEVICE COMBINATION MARKET: By PRODUCT, CAGR (2021-2028)

FIGURE 28 EUROPE DRUG-DEVICE COMBINATION MARKET: By PRODUCT, LIFELINE CURVE

FIGURE 29 EUROPE DRUG-DEVICE COMBINATION MARKET: By APPLICATION, 2020

FIGURE 30 EUROPE DRUG-DEVICE COMBINATION MARKET: By APPLICATION, 2019-2028 (USD million)

FIGURE 31 EUROPE DRUG-DEVICE COMBINATION MARKET: By APPLICATION, CAGR (2021-2028)

FIGURE 32 EUROPE DRUG-DEVICE COMBINATION MARKET: By APPLICATION, LIFELINE CURVE

FIGURE 33 Europe drug-device combination MARKET: BY END USER, 2020

FIGURE 34 Europe drug-device combination MARKET: BY product, 2021-2028 (USD MILLION)

FIGURE 35 Europe drug-device combination MARKET: BY product, CAGR (2021-2028)

FIGURE 36 Europe drug-device combination MARKET: BY product, LIFELINE CURVE

FIGURE 37 Europe drug-device combination MARKET: BY distribution channel, 2020

FIGURE 38 Europe drug-device combination MARKET: BY distribution channel, 2021-2028 (USD MILLION)

FIGURE 39 Europe drug-device combination MARKET: BY distribution channel, CAGR (2021-2028)

FIGURE 40 Europe drug-device combination MARKET: BY distribution channel, LIFELINE CURVE

FIGURE 41 EUROPE DRUG-DEVICE COMBINATION MARKET: SNAPSHOT (2020)

FIGURE 42 EUROPE DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020)

FIGURE 43 EUROPE DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2021 & 2028)

FIGURE 44 EUROPE DRUG-DEVICE COMBINATION MARKET: BY COUNTRY (2020 & 2028)

FIGURE 45 EUROPE DRUG-DEVICE COMBINATION MARKET: BY product (2021-2028)

FIGURE 46 EUROPE DRUG-DEVICE COMBINATION MARKET: COMPANY SHARE 2020 (%)

View Detailed Information Right Arrow

Research Methodology

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Customization Available

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Europe Drug-Device Combination Market thrives at a CAGR of 9.7% during its forecast period of 2022 to 2028.
The Europe Drug-Device Combination Market value flourishes with $6,359.42 million by 2028.
The geographical locations considered in the study of the report are U.K., Germany, France, Spain, Italy, Netherlands, Switzerland, Russia, Turkey, Belgium, and the rest of Europe.
Germany is now leading the Europe Drug-Device Combination Market rapidly due to the increasing advancement in the drug-device combination industry in the region.

Browse Related Pages

Banner